Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 151-157 , November 2006

Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer

Received 30 December 2005 ,Revised 26 June 2006 ,Accepted 15 September 2006.

References 

  1. Bucci MK, Bevan A, Roach M. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin. 2005;55:117–134
  2. Eisbruch A, Ship JA, Martel MK, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys. 1996;36:469–480
  3. Ozyigit G, Yang T, Chao KS. Intensity-modulated radiation therapy for head and neck cancer. Curr Treat Options Oncol. 2004;5:3–9
  4. Zhou J, Fei D, Wu Q. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose?. Int J Radiat Oncol Biol Phys. 2003;57:673–682
  5. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:663–673
  6. Marsh L, Eisbruch A, Watson B, Martel MK. Treatment planning for parotid sparing in the patient requiring bilateral neck irradiation. Med Dosim. 1996;21:7–13
  7. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14:199–212
  8. Purdy JA. 3D treatment planning and intensity-modulated radiation therapy. Oncology (Huntingt). 1999;13:155–168
  9. Verhey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol. 1999;9:78–98
  10. Breen SL, Kehagioglou P, Usher C, Plowman PN. A comparison of conventional, conformal and intensity-modulated coplanar radiotherapy plans for posterior fossa treatment. Br J Radiol. 2004;77:768–774
  11. Wu VW, Kwong DL, Sham JS. Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy. Radiother Oncol. 2004;71:201–206
  12. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999;45:577–587
  13. Huguenin PU, Taussky D, Moe K, et al. Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume. Int J Radiat Oncol Biol Phys. 1999;45:47–52
  14. Braaksma MM, Wijers OB, van Sornsen de Koste JR, et al. Optimisation of conformal radiation therapy by intensity modulation: cancer of the larynx and salivary gland function. Radiother Oncol. 2003;66:291–302
  15. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57:61–70
  16. Chao KS, Ozyigit G, Thorsdad WL. Toxicity profile of intensity-modulated radiation therapy for head and neck carcinoma and potential role of amifostine. Semin Oncol. 2003;30:101–108
  17. Cozzi L, Fogliata A, Bolsi A, Nicolini G, Bernier J. Three-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: comparative analysis of dosimetric and technical parameters. Int J Radiat Oncol Biol Phys. 2004;58:617–624
  18. Hong TS, Tome WA, Harari PM. Intensity-modulated radiation therapy in the management of head and neck cancer. Curr Opin Oncol. 2005;17:231–235
  19. Saarilahti K, Kouri M, Collan J, et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol. 2005;74:251–258
  20. Meyer J, Hummel SM, Cho PS, Austin-Seymour MM, Phillips MH. Automatic selection of non-coplanar beam directions for three-dimensional conformal radiotherapy. Br J Radiol. 2005;78:316–327
  21. Leavitt DD, Gibbs FA, Heilbrun MP, Moeller JH, Takach GA. Dynamic field shaping to optimize stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 1991;21:1247–1255
  22. Crooks SM, Wu X, Takita C, Watzich M, Xing L. Aperture modulated arc therapy. Phys Med Biol. 2003;48:1333–1344
  23. International Commission on Radiation Units and Measurements. ICRU Report 50. Prescribing, recording, and reporting photon beam therapy. Bethesda, MD, 1993.
  24. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  25. Niemierko A. Reporting, and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997;24:103–110
  26. Niemierko A. A generalized concept of equivalent uniform dose (EUD). Med Phys. 1999;26:1100
  27. Stefan L, Kwa S. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol. 1998;48:61–69
  28. Adams EJ, Convery DJ, Cosgrove VP, et al. Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement. Radiother Oncol. 2004;70:1–10
  29. MacKenzie MA, Robinson DM. Intensity modulated arc deliveries approximated by a large number of fixed gantry position sliding window dynamic multileaf collimator fields. Med Phys. 2002;29:2359–2365
  30. Wong E, D’Souza DP, Chen JZ, et al. Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies. Int J Radiat Oncol Biol Phys. 2005;61:830–841
  31. Duthoy W, De Gersem W, Vergote K, et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys. 2004;60:794–806
  32. Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys. 1993;20:1709–1719
  33. Sheng K, Jeraj R, Shaw R, Mackie TR, Paliwal BR. Imaging dose management using multi-resolution in CT-guided radiation therapy. Phys Med Biol. 2005;50:1205–1219
  34. Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys. 2002;52:224–235
  35. Tomita Y, Osaki T. Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment. Int J Oral Maxillofac Surg. 1990;19:299–304
  36. Spielman AI. Chemosensory function and dysfunction. Crit Rev Oral Biol Med. 1998;9:267–291
  37. Toljanic JA, Saunders VW. Radiation therapy and management of the irradiated patient. J Prosthet Dent. 1984;52:852–858
  38. Conger AD. Loss and recovery of taste acuity in patients irradiated to the oral cavity. Radiat Res. 1973;53:338–347

PII: S0167-8140(06)00481-6

doi: 10.1016/j.radonc.2006.09.004

Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 151-157 , November 2006